Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)

Krista A. Goulding, Adam Schwartz, Steven J. Hattrup, R. Lor Randall, Donald Lee, Damian M. Rispoli, Daniel M. Lerman, Christopher Beauchamp

Research output: Contribution to journalComment/debatepeer-review

Abstract

A financial disclosure statement was improperly reported in the published study, “Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.” The study should have included the following statement: “The institution of one of the authors (DL) has received, during the study period, funding from NCATS/NI1H (UL1 TR000445) for the utilization of the REDCap (Research Electronic Data Capture) database.” We apologize for the error.

Original languageEnglish (US)
Pages (from-to)1752
Number of pages1
JournalClinical orthopaedics and related research
Volume475
Issue number6
DOIs
StatePublished - Jun 1 2017

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Erratum to: Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity (Clinical Orthopaedics and Related Research®, (2017), 475, 6, (1702-1711), 10.1007/s11999-017-5258-0)'. Together they form a unique fingerprint.

Cite this